Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) Research & Development (2024 - 2025)

Historic Research & Development for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to $4.9 million.

  • Kestra Medical Technologies' Research & Development rose 3901.4% to $4.9 million in Q4 2025 from the same period last year, while for Oct 2025 it was $17.6 million, marking a year-over-year increase of 2176.38%. This contributed to the annual value of $15.7 million for FY2025, which is 104.58% up from last year.
  • Kestra Medical Technologies' Research & Development amounted to $4.9 million in Q4 2025, which was up 3901.4% from $4.0 million recorded in Q3 2025.
  • Kestra Medical Technologies' Research & Development's 5-year high stood at $5.4 million during Q2 2025, with a 5-year trough of $3.4 million in Q1 2025.